Close
Cancer trials monthly portfolio newsletter
This monthly newsletter showcases the Cancer Trials which are open to recruitment at the UCLH Clinical Research Facility.
Trials are listed with named Principal Investigator (PI), alongside a Local Project Reference (LRP) number for additional information on the trial, including eligibility criteria, linking to the ‘UCLH Find a Study database’ (https://findastudy.uclh.nhs.uk/#/trial).
Additionally, in this newsletter we highlight the research conducted by our cancer Principal Investigators, alongside the latest news coming from the cancer portfolio.
For more information on referring a patient, please visit the ‘Clinicians & Researchers’ webpage.
- January 2022
In this month's edition, we are pleased to highlight and introduce the appointment of three Cancer Consultants at the Clinical Research Facility. Dr. Khurum Khan in Gastro-Intestinal Oncology, Dr. Sarah Benafif in Thoracic Oncology and Dr. Anuradha Jayaram in Uro-Oncology.
Alongside, the recruitment of a new Band 7 Cancer Research Nurse, Jingle Sanchez. We welcome them all to the team.
- December 2021
Read the December 2021 Cancer Portfolio Newsletter:
In this month's edition, we are pleased to highlight news from the 63rd American Society of Haematology (ASH) Annual Meeting and Exposition held between 11th – 14th December, where CRF Cancer Principal Investigator and Consultant Haematologist, Dr. William Townsend, was lead author on an abstract presented at this international conference on the CO41942 clinical trial.
- November 2021
Read the November 2021 Cancer Portfolio Newsletter:
In this month's edition, we are pleased to highlight news from the UCLH Clinical Research Facility where a new Senior Cancer Research Nurse will soon join the team. We look forward to welcoming the new research nurse to the cancer programme and look forward to working with them in the coming new year.
- October 2021
Read the October 2021 Cancer Portfolio Newsletter:
In the October 2021 edition, we are showcasing Dr. Rakesh Popat. Rakesh Popat is a consultant haematologist at UCLH and honorary associate professor at University College London. He is the Cancer Lead at the NIHR UCLH Clinical Research Facility. He has highlighted his Myeloma early phase cancer trials, including 2 T-Cell engager trials (MMY1004: MajesTec 2 and GRACE) currently open to recruitment.
We are pleased to highlight news from the UCLH Clinical Research Facility where three new consultant appointments have been made in Thoracic Oncology, Gastro-intestinal Oncology and Uro-Oncology.
- September 2021
Read the September 2021 Cancer Portfolio Newsletter here:
In this edition, we are pleased to welcome our new UCLH Clinical Research Facility fellows to the team.
- August 2021
Read the August 2021 Cancer Portfolio Newsletter here:
- July 2021
Read the July 2021 Cancer Portfolio Nerwsletter here:
In this edition, we are pleased to highlight news from the American Society of Clinical Oncology (ASCO) 2021 annual meeting which was held as a virtual event between the 4th – 8th June.
3 cancer studies that were conducted at the UCLH CRF were featured at this international conference. Dr. Rakesh Popat co-authored on an abstract for the DREAMM-2 trial, Dr. William Townsend on the CRUKD/12/004 (AZD3965) trial and Dr. Martin Forster on the TACTI-002 trial.
- June 2021
Read the June 2021 Cancer Portfolio Newsletter here:
In the June 2021 edition, we are showcasing Dr. Dionysis Papadatos-Pastos. Dr. Papadatos-Pastos is a consultant medical oncologist and Principal Investigator specialising in the treatment of lung cancer and mesothelioma at University College London Hospitals. He has highlighted the CRUK-BT1718 clinical trial, currently open to recruitment.
We are pleased to highlight news from our UCLH Clinical Research Facility fellows, Dr. Aikaterini Kazantzi, who presented outcomes of the DREAMM-2 trial at two key haematology events.
- May 2021
Read the May 2021 Cancer Portfolio Newsletter here:
- April 2021
Read the April 2021 Cancer Portfolio Newsletter here:
- March 2021
Read the March 2021 Cancer Portfolio Newsletter here:
- In the March 2021 edition, we are showcasing Dr. Mark Linch. Dr. Linch is a Consultant Medical Oncologist and Associate Professor of Oncology at University College London (UCL) Cancer Institute where he leads the Urological Cancer Biology Group (UCBG). He has highlighted two cancer vaccine trials open to recruitment.
We are pleased to highlight news from our UCLH Clinical Research Facility fellows, Dr. Grisma Patel and Dr. Paramvir Sawhney, who both presented at international conferences in March.
- February 2021
Read the February 2021 Cancer Portfolio Newsletter here:
In the February 2021 edition we are showcasing Dr. William Townsend. Dr. Townsend is a consultant haematologist specialising in lymphoma. We are highlighting the bi-specific antibody trials he conducts.
We have news from the 62nd American Society of Haematology (ASH) annual congress where our haematology PIs have co-authored a number of early phase trial abstracts.
- January 2021
Read the January 2021 Cancer Portfolio Newsletter here:
In the January edition we are showcasing Dr. Sandra Strauss and the Sarcoma trials she conducts.